David Delurgio, MD
Clinical Cardiac Electrophysiology · Atlanta, GANPI 1144230509
Payments from drug & device makers
Across 1,794 payments — averaging $2363.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$1.8M
- Abbott$773K
- Medtronic$622K
- Atricure, Inc.$500K
- Adagio Medical, Inc.$323K
- Cardiva Medical, Inc.$160K
- plus $57K from 19 others
Across 185 payments — averaging $817.04 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$139K
- Atricure, Inc.$12K
What the payments were for
- Consulting fees$415,96360%
- Speaking & faculty fees$165,10724%
- Grants$1,5000%
- Travel & lodging$83,10312%
- Food & beverage$29,5884%
- Education$140%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 703 | $1,805,335 |
| Abbott | 396 | $772,988 |
| Medtronic(2 entities) | 110 | $621,941 |
| Atricure, Inc. | 419 | $499,637 |
| Adagio Medical, Inc. | 29 | $323,375 |
| Cardiva Medical, Inc. | 41 | $159,724 |
| Biosense Webster, Inc. | 20 | $30,767 |
| Haemonetics Corporation | 3 | $21,762 |
| Altathera Pharmaceuticals LLC | 3 | $2,640 |
| Acutus Medical, Inc. | 2 | $586 |
| Johnson & Johnson | 24 | $424 |
| Pfizer | 24 | $403 |
| Philips North America LLC | 5 | $233 |
| EBR Systems, Inc. | 1 | $98 |
| Vital Connect, Inc | 3 | $80 |
| Nuwellis, Inc. | 1 | $31 |
| Braemar Manufacturing, LLC | 1 | $31 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $29 |
| Innovation Technologies Inc | 1 | $24 |
| Sanofi-aventis U.S. LLC | 1 | $21 |
| Baxter Healthcare | 1 | $20 |
| Angiodynamics, Inc. | 1 | $19 |
| E.r. Squibb & Sons, L.L.C. | 1 | $16 |
| Cordis US CORP. | 1 | $15 |
| Kestra Medical Technology Services, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX$216,837
- Watchman$98,419
- WATCHMAN Access System$53,105
- WATCHMAN FLX$40,305
- Farapulse$33,461
- ATRICLIP LAA EXCLUSION SYSTEM$32,943
- TACTICATH ABLATION CATHETER, SENSOR ENABLED$24,234
- Cardiva VASCADE MVP VVCS 6-12F$24,176
- GENERAL - THERAPIES$22,733
- CARDIVA VASCADE MVP XL VVCS 10-12F$21,887
- Cardiva VASCADE 5F VCS$18,887
- Cardiva VASCADE 6/7F VCS$18,887
- EPI-SENSE GUIDED COAGULATION SYS$13,428
- SYNERGY ABLATION SYSTEM$11,814
- ATRICURE CRYOICE CRYOSPHERE CRYOABLATION SYSTEM$5,152
- CLINICAL TRIAL PRODUCT$4,621
- Sotalol Hydrochloride$2,640
- ARCTIC FRONT ADVANCE$2,232
- Vascular Closure Device$1,813
- Accent Pacemaker$1,650
How this compares
$4,240,213 in reported general payments places this provider in the 95th percentile of 93 clinical cardiac electrophysiology providers in Georgia.
See all clinical cardiac electrophysiology providers in Georgia →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 569 | $669,715 |
| XareltoRivaroxaban | 186 | $217,106 |
| MultaqDronedarone Hcl | 19 | $41,363 |
| Dofetilide | 93 | $20,076 |
| Flecainide Acetate | 338 | $13,823 |
| SotalolSotalol Hcl | 277 | $6,030 |
| Dabigatran EtexilateDabigatran Etexilate Mesylate | 25 | $5,168 |
| Mexiletine Hcl | 29 | $3,573 |
| Metoprolol Succinate | 258 | $3,006 |
| Sucralfate | 48 | $2,347 |
| Propafenone Hcl | 19 | $1,360 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 37 | $1,129 |
| Amiodarone Hcl | 76 | $787 |
| Losartan Potassium | 54 | $592 |
| Amlodipine Besylate | 50 | $482 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $403 | $669,715569 claims |
| Johnson & JohnsonXarelto | $424 | $217,106186 claims |
| Sanofi-aventis U.S. LLCMultaq | $21 | $41,36319 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 93 clinical cardiac electrophysiology providers in Georgia.
Other clinical cardiac electrophysiology in Atlanta
- Sandeep GoyalAtlanta$1.3M
- Mikhael El-ChamiAtlanta$1.1M
- Sricharan KantipudiAtlanta$663K
- Anshul PatelAtlanta$615K
- Michael LloydAtlanta$444K
- Anand ShahAtlanta$380K
- Thomas DeeringAtlanta$237K
- Faisal MerchantAtlanta$215K
- Stacy WestermanAtlanta$149K
- Bruce StamblerAtlanta$136K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.